Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Maurie Markman; William Kelly

Premium

Cancer Treatment Centers of America has appointed Maurie Markman as president of its medicine and science unit. Previously, Markman was senior VP of clinical affairs and national director of medical oncology at CTCA.

In his new position, Markman will lead CTCA's national clinical team. He is an expert in the field of medical oncology and clinical research, and has conducted “pioneering work” in advanced genomic testing, CTCA CEO Gerard van Grinsven said in a statement. Throughout his career, Markman has held various leadership roles at many leading cancer institutions, including The Cleveland Clinic, the University of Texas MD Anderson Cancer Center, and The Ohio State University.


Exosome Diagnostics has appointed William Kelly as its chief financial officer, effective May 27. Kelly has two decades of financial management experience and spent 13 years leading life sciences firms. He served as chief financial officer of RepliGen Corporation since 2008. Before that, Kelly was corporate controller of Haemonetics Corporation.

Filed under

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.